3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumors
1
Sarcoma
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
146
pembrolizumab
118
Magnetic Resonance Spectroscopy
117
Cyclophosphamide
113
Biopsy
96
fludarabine
88
Nivolumab
52
Carboplatin
51
Cisplatin
47
Gemcitabine
46
Radiotherapy
41
venetoclax
40
Cetuximab
40
fludarabine phosphate
39
Paclitaxel
39
Ipilimumab
34
atezolizumab
33
Fluorouracil
33
Bevacizumab
32
Oxaliplatin
27
Leucovorin
27
Dexamethasone
26
durvalumab
25
X-Rays
25
Irinotecan
25
Radiation
24
Cytarabine
23
Azacitidine
23
Injections
22
Temozolomide
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Angptl4 protein, mouse
×
90 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled